期刊文献+

HPV E6/E7 mRNA在CINⅡ及以上病变中的诊断价值 被引量:12

The diagnostic value of human papilloma virus E6/E7 mRNA detection in CINⅡ+
暂未订购
导出
摘要 目的:探讨人乳头瘤病毒(HPV)E6/E7 m RNA检测在CINII及以上宫颈病变(CINII+)诊断中的应用价值。方法:2014年1月至9月在温州市人民医院妇科门诊行宫颈筛查发现新柏超薄液基细胞学检查(TCT)≥未明确意义的非典型鳞状上皮细胞(ASCUS)和/或高危HPV DNA阳性的患者426例,其中TCT结果为ASCUS者156例,均行宫颈HPV E6/E7 m RNA检测和组织病理学检查。根据病理结果将病例分为5组,分析HPV E6/E7 m RNA拷贝数与病变程度的相关性。利用受试者工作特征(ROC)曲线评价HPV E6/E7 m RNA对ASCUS患者CINII+的预测价值。结果:宫颈癌组HPV E6/E7 m RNA拷贝数最高,慢性子宫颈炎组拷贝数最低。Spearman等级相关分析显示组织学病变程度与HPV E6/E7 m RNA水平与之间存在正相关性(r=0.549,P<0.001)。在CINII+中,HPV E6/E7 m RNA阳性率为91.6%,HR-HPV DNA阳性率为93.0%,差异无统计学意义(x2=0.197,P>0.05)。ROC曲线显示,HPV E6/E7 m RNA预测CINII+最佳临界值为147.965。HPV E6/E7 m RNA与HR-HPV DNA检测预测ASCUS患者CINII+的灵敏度、阴性预测值相比较,差异均无统计学意义(P>0.05);两者特异度、阳性预测值比较,差异有统计学意义(P<0.05)。结论:随着宫颈病变程度增加,HPV E6/E7 m RNA拷贝数相应增加。与HPV DNA检测方法相比,HPV E6/E7 m RNA检测对ASCUS患者CINII+的特异度、阳性预测值更高,可作为ASCUS患者分流管理的有效措施。 Objective:To evaluate the application value of detecting human papilloma virus(HPV) E6/E7 m RNA as a diagnose test for CINII+.Methods:From January to October in 2014,a total of 426 gynecological outpatients,whose TCT≥ASCUS or/and high-risk HPV DNA positive,were found by cervical lesions screening in Wenzhou People's Hospital.All those outpatients performed HPV E6/E7 m RNA detection and histopathological examination.According to different histological results,samples were divided into 5 groups,the correlation between the expression of HPV E6/E7 m RNA and the severity of cervical lesions were analyzed.The ROC curve was used to assess the predictive value of HPV E6/E7 m RNA for CINII+ of ASCUS.Results:The cervical cancer group had the highest level of HPV E6/E7 m RNA while the chronic cervical inflammation group had the lowest.Spearman rank analysis demonstrated that the severity of cervical lesions was proportional to the expression of HPV E6/E7 m RNA(r=0.549,P〈0.001).For CINII+,there was no significant difference between HPV E6/E7 m RNA and high-risk HPV DNA in positive rate(x2=0.197,P〈0.05).The ROC curve showed that HPV E6/E7 m RNA147.965 were superior to any other standards to scan CINII+.The sensitivity and negative predictive value of HPV E6/E7 m RNA and HR-HPV DNA in predicting CINII+ of patients with ASCUS showed no statistically significant difference(P〈0.05),while the specificity and positive predictive value showed statistically significant difference(P〈0.05).Conclusion:The copy number of HPV E6/E7 m RNA transcripts is correlated with severe degree of epithelial cervical dysplasia.The specificity and positive predictive value of HPV E6/E7 m RNA detection are higher than those of HPV DNA for diagnosis of CINII+ in patients with ASCUS,therefore HPV E6/E7 m RNA detection may be a valuable tool for triage and patient follow-up.
出处 《温州医学院学报》 CAS 2015年第8期583-587,共5页 Journal of Wenzhou Medical College
关键词 E6/E7 MRNA 人乳头瘤病毒 DNA 宫颈病变 E6/E7 m RNA human papilloma virus DNA cervical lesions
  • 相关文献

参考文献12

  • 1谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 2Dogan NU, Salman MC, Yuce K. The role of HPV DNA testing in the follow-up of cervical intraepithelial neoplasia after loop electrosurgical excision procedure[J]. Arch Gyne- col Obstet, 2011, 283(4): 871-877.
  • 3赵超,魏丽惠.干扰素α-2b对宫颈癌细胞HPV16 E6E7基因抑制作用的研究[J].中国妇产科临床杂志,2005,6(3):192-195. 被引量:14
  • 4谢红,杨菊芳,谢懿,王莉菲.宫颈细胞学涂片为ASCUS的处理方法探讨[J].实用医学杂志,2006,22(6):699-700. 被引量:52
  • 5曾晓琴,武秋林,李萍,苏红梅,朱长艳,陈文婷,叶党英.两种宫颈涂片细胞学分类法的应用研究[J].国外医学(妇幼保健分册),2005,16(6):346-348. 被引量:25
  • 6Massad LS, Einstein MH, Huh WK, et al. 2012 updated con- sensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[J]. J Low Genit Tract Dis, 2013, 17(5 Suppl 1): S1-S27.
  • 7Zur Hausen H. Papillornaviruses and cancer: from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2(5): 342-350.
  • 8Kwan TT, Cheung AN, Lo SS, et al. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study [J]. Acta Obstet Gynecol Scand, 2011, 90(5): 445-451.
  • 9Benevolo M, Vocaturo A, Caraceni D, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for cervical cy- tology and HPV DNA Test[J]. J Clin Microbiol, 2011, 49(7): 2643-2650.
  • 10孙玲玲,陈伟,王丽娜.宫颈细胞学不典型鳞状细胞诊断及检测的研究进展[J].实用妇产科杂志,2013,29(7):499-502. 被引量:9

二级参考文献22

  • 1[2]Munoz N,Bosch FX,Sanjose S,et al.Epidemiologic classification of humanpapillomavirus types associated with cervical cancer.N Engl J Med,2003,348:518-527.
  • 2[3]Einstein MH,Goldberg GL.Human papillomavirus and cervical neoplasia.Cancer Invest,2002,20:1080-1085.
  • 3[4]Bosch FX,Munoz N.The viral etiology of cervical cancer.Virus Res,2002,89:183-190.
  • 4[5]Ronco LV,Karpova AY,Vidal M,et al.Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.Genes Dev,1998,12:2061-2072.
  • 5[6]Nees M,Geoghegan JM,Munson P,et al.Human papillomavirus type 16 and E7 proteins inhibit differentiation - dependent expression of tansforming growth factor - beta 2 in cervical keratinocytes.Cancer Res,2000,60:4289-4298.
  • 6[7]Lippman SM,Kavanagh JJ,Paredes-Espinoza M,et al.13-cis-retinoic acid plus interferon-α-2a:Highly active systemic therapy for squamous cell carcinoma of the cervix.J Natl Cancer Inst,1992,84:241-245.
  • 7[8]Stellato G.Intralesional recombinant alpha 2B interferon in the treatment of human papillomavirus-associated cervical intraepithelial neoplasia.Sex.Trans.Dis,1992,19:124-126.
  • 8[9]Meyskens FL,Surwit E,Moon TE,et al.Enhancement of regression of cervical intraepithelial neoplasia Ⅱ(moderate dysplasia) with topically applied all-trans-retinoic acid:A randomized trial.J Natl Cancer Inst,1994,86:539-543.
  • 9[10]A.E.Koromilas,Suiyang Li,Gregory Matlashewski.Control of interferon signaling in human papillomavirus infection.Cytokine & Growth Factor Reviews,2001,12:157-170.
  • 10[11]zur Hausen H.Human papillomaviruses in the pathogenesis of anogenital cancer.Virology,1991,184:9-13.

共引文献1336

同被引文献108

  • 1王华,陈亚宝,叶丽华,叶军,袁冬兰.应用支链DNA技术检测人乳头瘤病毒E6/E7mRNA在宫颈疾病筛查中的价值[J].中华临床医师杂志(电子版),2011,5(15):4362-4366. 被引量:29
  • 2郑曙民,陈星,籍海红,王慧.子宫颈癌患者人乳头瘤病毒16、18检测[J].肿瘤研究与临床,2008,20(1):48-49. 被引量:3
  • 3Parkin DM. The global health burden of infection-associated cancers in the year 2002 [J]. Int J Cancer, 2006,118(12): 3O30-3O44.
  • 4Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia[J]. Cancer Epidem Biomar,2008,17(10) : 2536-2545.
  • 5Hovland S,Muller S, Skomedal H,et al. E6 /E7 mRNA ex- pression analysis: a test for the objective assessment of cervi- cal adenocar cinomain clinical prognostic procedure[J]. Int J Oncol,2010,36 ( 6)1533-1539.
  • 6Werness BA,Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53[J]. Sci- ence,1990,248(4951) : 76-79.
  • 7MeLaughlin-Drubin ME, Miinger K. The human papilloma- virus E7 oneoprotein[J]. Virology,2009,384(2) : 335-344.
  • 8Jung YS,Kato l,Kim HRC. A novel {unction of HPV16-E6 / E7 in epithelial-mesenchymal transition[J]. Bioehe Bioph Res Co,2013,435(3) : 339- 344.
  • 9Ghittoni R, Accardi R, H asan U,et al. The biologieal proper- ties of E6 and E7 oneoproteins from human papillomaviruses [J]. Virus Genes,2010,40(1) : 1-13.
  • 10Rossi PG,Benevolo M,Vocaturo A,et al. Prognostic value of HPV E6 /E7 mRNA assay in women with negative colposco- py or CIN1 histology result: a follow-up study[J]. PLoS One,2013,8 (2) :e57600.

引证文献12

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部